Abstract
Androgen and androgen receptor (AR) signaling are crucial for the genesis of prostate cancer (PCa), which can often develop into androgen-ligand-independent diseases that are lethal to the patients. Recent studies show that even these hormone-refractory PCa require ligand-independent AR signaling for survival. As current chemotherapy is largely ineffective for PCa and has serious toxic side-effects, we have initiated a collaborative effort to identify and develop novel, safe and naturally occurring agents that target AR signaling from Oriental medicinal herbs for the chemoprevention and treatment of PCa. We highlight our discovery of decursin from an Oriental formula containing Korean Angelica gigas Nakai (Dang Gui) root as a novel anti-androgen/AR agent. We have identified the following mechanisms to account for the specific anti-AR actions: rapid block of AR nuclear translocation, inhibition of binding of 5α-dihydrotestesterone to AR and increased proteasomal degradation of AR protein. Furthermore, decursin lacks the agonist activity of the “pure” anti-androgen bicalutamide and is more potent than bicalutamide in inducing PCa apoptosis. Structure-activity analyses reveal a critical requirement of the side-chain on decursin or its structural isomer decursinol angelate for anti-AR, cell cycle arrest and proapoptotic activities. This work demonstrates the feasibility of using activity-guided fractionation in cell culture assays combined with mechanistic studies to identify novel anti-androgen/AR agents from complex herbal mixtures.
Similar content being viewed by others
Article PDF
References
Heinlein CA, Chang C . Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276–308.
Taplin ME, Balk SP . Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004; 91: 483–90.
Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ . Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002; 62: 1008–13.
Chen S, Song CS, Lavrovsky Y, Bi B, Vellanoweth R, Chatterjee B, et al. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Mol endocrinol 1998; 12: 1558–66.
Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T . “Decoy” of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 1999; 41: 121–6.
Liao X, Tang S, Thrasher JB, Griebling TL, Li B . Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 2005; 4: 505–15.
Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. New Engl J Med 2003; 349: 215–24.
Balk SP, Ko YJ, Bubley GJ . Biology of prostate-specific antigen. J Clin Oncol 2003; 21: 383–91.
Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ . Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 1991; 51: 3748–52.
Montgomery BT, Young C Y, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, et al. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 1992; 21: 63–73.
Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ . Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001; 142: 4795–805.
Zi X, Agarwal R . Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci USA 1999; 96: 7490–5.
Lee HJ, Lee EO, Rhee YH, Ahn KS, Li GX, Jiang C, et al. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis 2006; 27: 2455–63.
Jiang C, Lee HJ, Li GX, Guo J, Malewicz B, Zhao Y, et al. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res 2006; 66: 453–63.
Ahn KS, Sim WS, Kim IH . Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med 1996; 62: 7–9.
Kim HH, Ahn KS, Han H, Choung SY, Choi SY, Kim IH . Decursin and PDBu: two PKC activators distinctively acting in the mega-karyocytic differentiation of K562 human erythroleukemia cells. Leuk Res 2005; 29: 1407–13.
Chi HJ, Kim HS . Studies on the components of Umbelliferae plants in Korea: pharmacological study of decursin, decursinol and nodakenin. Korean J Pharmacol 1970; 1: 25–32.
Guo J, Jiang C, Wang Z, Lee HJ, Hu H, Malewicz B, et al. A novel class of pyranocoumarin anti-androgen receptor signaling compounds. Mol Cancer Ther 2007; 6: 907–17.
Sheflin L, Keegan B, Zhang W, Spaulding SW . Inhibiting protea-somes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun 2000; 276: 144–50.
Diehl JA, Zindy F, Sherr CJ . Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11: 957–72.
Ahn KS, Sim WS, Lee IK, Seu YB, Kim IH . Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas. Planta Med 1997; 63: 360–1.
Sarker SD, Nahar L . Natural medicine: the genus Angelica. Curr Med Chem 2004; 11: 1479–500.
Schellhammer PF, Davis JW . An evaluation of bicalutamide in the treatment of prostate cancer. Clin Prostate Cancer 2004; 2: 213–9.
Hata K, Sano K . Studies on coumarins from the root of Angelica decursiva FR et SAV. I. The structure of decursin and decursidin. Yakugaku Zasshi 1969; 89: 549–57.
Konoshima M, Chi HJ, Hata K . Coumarins from the root of Angelica gigas Nakai. Chem Pharm Bull 1968; 16: 1139–40.
Woo YA, Kim HJ, Ze KR, Chung H . Near-infrared (NIR) spectroscopy for the non-destructive and fast determination of geographical origin of Angelicae gigantis Radix. J Pharm Biomed Anal 2005; 36: 955–9.
Kim MR, El-Aty AM, Choi JH, Lee KB, Shim JH . Identification of volatile components in Angelica species using supercritical-CO2 fluid extraction and solid phase microextraction coupled to gas chromatography-mass spectrometry. Biomed Chromatogr 2006; 20: 1267–73.
Kang SY, Lee KY, Sung SH, Park MJ, Kim YC . Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. Journal of natural products 2001; 64: 683–5.
Kang SY, Lee KY, Sung SH, Kim YC . Four new neuroprotective dihydropyranocoumarins from Angelica gigas. J Nat Prod 2005; 68: 56–9.
Choi SS, Han KJ, Lee HK, Han EJ, Suh HW . Antinociceptive profiles of crude extract from roots of Angelica gigas NAKAI in various pain models. Biol Pharm Bull 2003; 26: 1283–8.
Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, et al. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci 2003; 73: 471–85.
Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, et al. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003; 79: 11–8.
Lee S, Shin DS, Kim JS, Oh KB, Kang SS . Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res 2003; 26: 449–52.
Lee Y Y, Lee S, Jin JL, Yun-Choi HS . Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas. Arch Pharm Res 2003; 26: 723–6.
Ohshiro T, Namatame I, Lee EW, Kawagishi H, Tomoda H . Molecular target of decursins in the inhibition of lipid droplet accumulation in macrophages. Biol Pharm Bull 2006; 29: 981–4.
Kim JH, Jeong JH, Jeon ST, Kim H, Ock J, Suk K, et al. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Mol Pharmacol 2006; 69: 1783–90.
Kim HH, Sik Bang S, Seok Choi J, Han H, Kim IH . Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells. Cancer Lett 2005; 223: 191–201.
Yim D, Singh R P, Agarwal C, Lee S, Chi H, Agarwal R . A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 2005; 65: 1035–44.
Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS . Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Arch Pharm Res 2003; 26: 727–30.
Shin D, Kim H, Jang K, Kim H, Chung H, Kong G . The in vitro and in vivo anti-tumor effect of decursin in estrogen receptor-negative human breast cancer cells occurs via downregulation of Akt signaling pathway. [abstract]. In: American Association for Cancer Research Annual Meeting: Proceedings; 2007 Apr 14–18; Los Angeles, CA. Philadelphia (PA): AACR; 2007. Abstract nr 447.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This work was supported in part by the Hormel Foundation, The Prostate Cancer Foundation and National Cancer Institute grant CA95642 to Junxuan LÜ, and by grants from the Korean Biogreen21 Project and Ministry of Health and Welfare, and BRP and CPMRC grants from KOSEF to Sunghoon KIM.
Rights and permissions
About this article
Cite this article
Lü, J., Kim, SH., Jiang, C. et al. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents. Acta Pharmacol Sin 28, 1365–1372 (2007). https://doi.org/10.1111/j.1745-7254.2007.00683.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00683.x
Keywords
This article is cited by
-
Decursinol chloroacrylates useful as fungicides
Applied Biological Chemistry (2022)
-
A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo
Investigational New Drugs (2012)
-
In Vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes
Archives of Pharmacal Research (2008)